Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion
Year: 2025
Type: article
Language: en
Topic: Ovarian cancer diagnosis and treatment
Authors and affiliations:
raw_author_name: Sarina A Piha-Paul
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Chieh Tseng
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Emily Thompson
raw_affiliation_strings: Department of Imaging Physics, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Imaging Physics, Division of Radiology, , Houston, TX
raw_author_name: R Jason Stafford
raw_affiliation_strings: Department of Imaging Physics, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Imaging Physics, Division of Radiology, , Houston, TX
raw_author_name: Hung Le
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Lei Kang
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Siqing Fu
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Apostolia Tsimberidou
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: George Blumenschein
raw_affiliation_strings: Department of Thoracic and Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Thoracic and Head and Neck Medical Oncology, Division of Cancer Medicine, , Houston, TX
raw_author_name: Jordi Rodon Ahnert
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: John M Slopis
raw_affiliation_strings: Department of Neuro-Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Neuro-Oncology, Division of Cancer Medicine, , Houston, TX
raw_author_name: David Hong
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Aung Naing
raw_affiliation_strings: Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), , Houston, TX
raw_author_name: Funda Meric-Bernstam
raw_affiliation_strings: Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, , Houston, TX
University of Texas, MD Anderson Cancer Center Department of Breast Surgical Oncology, Division of Surgery, , Houston, TX
raw_author_name: Chaan S Ng
raw_affiliation_strings: Department of Abdominal Imaging, Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas MD Anderson Cancer Center Department of Abdominal Imaging, Division of Radiology, , Houston, TX
raw_author_name: Shannon Westin
raw_affiliation_strings: Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas, MD Anderson Cancer Center Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, , Houston, TX
raw_author_name: Anil K Sood
raw_affiliation_strings: Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, University of Texas MD Anderson Cancer Center , Houston, TX, 77030,
University of Texas, MD Anderson Cancer Center Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, , Houston, TX